FOLD — Amicus Therapeutics Share News
0.000.00%
Last trade - 00:00- $4.55bn
- $4.65bn
- $634.21m
Brief: Amicus Therapeutics Q4 net income USD -33.8 million
Amicus Therapeutics Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: Amicus Therapeutics Inc John F. Crowley Will Step Down From Amicus Board Of Directors
Brief: Amicus Therapeutics Inc Files Prospectus Related To Resale Of Up To 2.5 Million Shares Of Common Stock By Selling Stockholders-SEC Filing
Brief: Amicus Therapeutics Total Revenue Was $103.5 Million In Q3 2023, Increase Of 27%
Brief: Amicus Therapeutics Q3 Revenue USD 103.5 Million Vs. IBES Estimate USD 101.4 Million
Brief: Amicus Therapeutics Inc-Hayfin Loan Agreement Of July, 2020 Was Terminated Effective Oct 5
U.S. STOCKS ON THE MOVE-Mercato, Baytex, Ball Corp
U.S. STOCKS ON THE MOVE-SeaStar, Sigma Lithium, Brinker
U.S. STOCKS ON THE MOVE-OPKO Health, Structure Therapeutics, Blue Apron
U.S. STOCKS ON THE MOVE-premarket
J.P.Morgan sees Amicus Therapeutics soaring 60% by end-2024
U.S. RESEARCH ROUNDUP-Brinker International, Jabil, Nike
US FDA approves Amicus Therapeutics' muscle disorder treatment (updated)
U.S. FDA approves Amicus Therapeutics' muscle disorder treatment
Brief: Amicus Therapeutics Appoints Simon Harford As CFO
U.S. RESEARCH ROUNDUP-Appfolio, Marqeta, Target
U.S. STOCKS ON THE MOVE-Arcellx, U.S. Steel, Copper miners
U.S. STOCKS ON THE MOVE-Getty Images, Tiziana, LL Flooring